AusPAR: Nuvaxovid

Australian Public Assessment Report (AusPAR)

AusPAR

AusPAR: nuvaxovid [PDF, 3.4 MB]

AusPAR: nuvaxovid [Word, 3.23 MB]

AusPAR Attachment 1: Product Information for nuvaxovid [PDF, 601.01 KB]

AusPAR Attachment 1: Product Information for nuvaxovid [Word, 87.7 KB]

Device/Product Name

Nuvaxovid

Active ingredients

SARS-CoV-2-rS (NVX-CoV2373)

AusPAR Date

6 November 2023

Published

7 November 2023

Submission Number

PM-2023-01692-1-2

Submission Type

Transition from provisional registration to full registration

Decision

Approved